证券记录 · 已归档季度
GMED
Globus Medical, Inc. · Healthcare · Medical - Devices
19被追踪持有人
-2Δ持有人
35.55M持有股份
$2.10B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -9.5% ·
股份流向 +2.1% ·
净新建仓位 -10.5%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 80.59K | $4.78M | n/a | n/a |
| Q2 2026 | 123 | -3 | 71.27M | $5.66B | +7 | −9 |
| Q1 2026 | 128 | +3 | 69.73M | $6.00B | +7 | −5 |
| Q4 2025 | 125 | -2 | 72.17M | $6.30B | +1 | −2 |
| Q3 2025 | 23 | +2 | 41.89M | $2.40B | +2 | −1 |
| Q2 2025 | 19 | -2 | 35.55M | $2.10B | n/a | −2 |
| Q1 2025 | 18 | +2 | 12.57M | $919.97M | +3 | −1 |
| Q4 2024 | 16 | 0 | 17.69M | $1.46B | +1 | −1 |
| Q3 2024 | 15 | 0 | 11.77M | $842.11M | +1 | −1 |
| Q2 2024 | 15 | n/a | 12.93M | $885.43M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 10.76M | n/a | $635.26M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 2 | The Vanguard Group ✦ (被动) | 10.71M | n/a | $632.04M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 3.47M | -3.9% | $205.00M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 1.99M | -1.9% | $117.67M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 1.97M | +4.6% | $116.19M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 6 | Marshall Wace ✦ | 1.58M | +89.7% | $93.28M | 0.1% | ▲ Add | 5 | SEC ↗ ×3 |
| 7 | Norges Bank ✦ (被动) | 1.15M | +2.5% | $68.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 1.07M | -6.4% | $63.43M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 9 | Fidelity (FMR) ✦ | 760.38K | n/a | $44.88M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 10 | Capital World Investors ✦ | 574.50K | 0.0% | $33.91M | 0.0% | Held | 5 | SEC ↗ |
| 11 | Bridgewater Associates ✦ | 436.64K | +228.0% | $25.77M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 288.07K | -12.9% | $17.00M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 244.08K | +91.0% | $14.41M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 14 | GAMCO Investors ✦ | 135.29K | +1.1% | $7.98M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 112.00K | +397.6% | $6.59M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 16 | Renaissance Technologies ✦ | 105.42K | -40.4% | $6.22M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 103.47K | +34.3% | $6.11M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | PRIMECAP Management ✦ | 35.62K | -7.5% | $2.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Millennium Management ✦ | 34.23K | +150.8% | $2.02M | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Citadel Advisors | $20.89M | 曾为 0.0% |
| Two Sigma Investments | $1.23M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 598 持有人, 106.58M 股份, $8.83B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 15
TOBIN JAMES R
Director · 30.00K 股 · $2.24M
Aug 18
ZARRILLI STEPHEN T
Director · 25.00K 股 · $2.18M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据